Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia

Aravind Krishnan; Alejandro Suarez-Pierre; Todd C. Crawford; Xun Zhou; Stuart D. Russell; Ronald D. Berger; Hugh Calkins; William A. Baumgartner; Harikrishna Tandri; Kaushik Mandal

doi:10.1016/j.athoracsur.2017.09.023

Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia

Aravind Krishnan, Alejandro Suarez-Pierre, Todd C. Crawford, Xun Zhou, Stuart D. Russell, Ronald D. Berger, Hugh Calkins, William A. Baumgartner, Harikrishna Tandri, Kaushik Mandal

School of Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

We describe the novel use of bilateral cardiac sympathectomy in a woman with end-stage heart failure caused by ventricular tachycardia refractory to standard medical therapy who was under consideration for heart transplantation. Postoperatively, our patient has not experienced any symptoms of ventricular tachycardia, has returned to normal physical activity, and is no longer under consideration for transplantation as a result of the improvement in her cardiac function. Bilateral sympathectomy can be more effective than unilateral sympathectomy or percutaneous stellate ganglion blockade in patients with refractory ventricular tachycardia. Careful patient selection is necessary to identify patients who will benefit most from the procedure.

Original language	English (US)
Pages (from-to)	e51-e53
Journal	Annals of Thoracic Surgery
Volume	105
Issue number	2
DOIs	https://doi.org/10.1016/j.athoracsur.2017.09.023
State	Published - Feb 2018

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.athoracsur.2017.09.023

Cite this

@article{be9f75a6fe2a4befb0bb8c8b81904cf0,

title = "Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia",

abstract = "We describe the novel use of bilateral cardiac sympathectomy in a woman with end-stage heart failure caused by ventricular tachycardia refractory to standard medical therapy who was under consideration for heart transplantation. Postoperatively, our patient has not experienced any symptoms of ventricular tachycardia, has returned to normal physical activity, and is no longer under consideration for transplantation as a result of the improvement in her cardiac function. Bilateral sympathectomy can be more effective than unilateral sympathectomy or percutaneous stellate ganglion blockade in patients with refractory ventricular tachycardia. Careful patient selection is necessary to identify patients who will benefit most from the procedure.",

author = "Aravind Krishnan and Alejandro Suarez-Pierre and Crawford, {Todd C.} and Xun Zhou and Russell, {Stuart D.} and Berger, {Ronald D.} and Hugh Calkins and Baumgartner, {William A.} and Harikrishna Tandri and Kaushik Mandal",

note = "Publisher Copyright: {\textcopyright} 2018 The Society of Thoracic Surgeons",

year = "2018",

month = feb,

doi = "10.1016/j.athoracsur.2017.09.023",

language = "English (US)",

volume = "105",

pages = "e51--e53",

journal = "Annals of Thoracic Surgery",

issn = "0003-4975",

publisher = "Elsevier USA",

number = "2",

}

TY - JOUR

T1 - Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia

AU - Krishnan, Aravind

AU - Suarez-Pierre, Alejandro

AU - Crawford, Todd C.

AU - Zhou, Xun

AU - Russell, Stuart D.

AU - Berger, Ronald D.

AU - Calkins, Hugh

AU - Baumgartner, William A.

AU - Tandri, Harikrishna

AU - Mandal, Kaushik

PY - 2018/2

Y1 - 2018/2

N2 - We describe the novel use of bilateral cardiac sympathectomy in a woman with end-stage heart failure caused by ventricular tachycardia refractory to standard medical therapy who was under consideration for heart transplantation. Postoperatively, our patient has not experienced any symptoms of ventricular tachycardia, has returned to normal physical activity, and is no longer under consideration for transplantation as a result of the improvement in her cardiac function. Bilateral sympathectomy can be more effective than unilateral sympathectomy or percutaneous stellate ganglion blockade in patients with refractory ventricular tachycardia. Careful patient selection is necessary to identify patients who will benefit most from the procedure.

AB - We describe the novel use of bilateral cardiac sympathectomy in a woman with end-stage heart failure caused by ventricular tachycardia refractory to standard medical therapy who was under consideration for heart transplantation. Postoperatively, our patient has not experienced any symptoms of ventricular tachycardia, has returned to normal physical activity, and is no longer under consideration for transplantation as a result of the improvement in her cardiac function. Bilateral sympathectomy can be more effective than unilateral sympathectomy or percutaneous stellate ganglion blockade in patients with refractory ventricular tachycardia. Careful patient selection is necessary to identify patients who will benefit most from the procedure.

UR - http://www.scopus.com/inward/record.url?scp=85041345974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041345974&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2017.09.023

DO - 10.1016/j.athoracsur.2017.09.023

M3 - Article

C2 - 29362191

AN - SCOPUS:85041345974

SN - 0003-4975

VL - 105

SP - e51-e53

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 2

ER -

Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this